Reporting Manager
Balyasny Asset Management L.P.
Symbol
IRD
Shares outstanding
71,175,111 shares
Disclosed Ownership
5,110,373 shares
Ownership
7.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2026, 06:38:36 UTC
Date of event
31 Mar 2026
Previous filing
17 Feb 2026

Key filing fact

BALYASNY ASSET MANAGEMENT L.P. disclosed 7.2% ownership in Opus Genetics Inc. Common Stock, par value $0.0001 per share (IRD) on 31 Mar 2026.

Key facts

  • BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A for Opus Genetics Inc. Common Stock, par value $0.0001 per share (IRD).
  • Disclosed ownership: 7.2%.
  • Date of event: 31 Mar 2026.

Change

  • Previous schedule filing date: 17 Feb 2026.
  • Current filing was accepted on 15 May 2026, 06:38.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (5)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 7.2% 5,110,373 5,110,373 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 7.2% 5,110,373 5,110,373 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 7.2% 5,110,373 5,110,373 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 7.2% 5,110,373 5,110,373 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 7.2% 5,110,373 5,110,373 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .